HSA
NUTX

Hussman Strategic Advisors’s Nutex Health NUTX Stock Holding History

Hussman Strategic Advisors’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,000
Closed -$2M – 294
2026
Q1 		$2M Hold
21,000
– – 0.43% 105
2025
Q4 		$3.46M Buy
+21,000
New +$2.79M 0.84% 12

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Hussman Strategic Advisors's NUTX Position: Q2 2026 in Review

Hussman Strategic Advisors sold out of Nutex Health (NUTX) in Q2 2026, closing a stake of 21,000 shares — an estimated $2M sold.

Hussman Strategic Advisors first reported a position in NUTX in Q4 2025 and held it in 2 quarters. The position peaked at $3.46M in Q4 2025. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Hussman Strategic Advisors reported no remaining Nutex Health position as of Q2 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 21,000 Nutex Health shares in Q2 2026, an estimated $2M.
  • Hussman Strategic Advisors first reported a position in Nutex Health in Q4 2025 and held it in 2 quarters.
  • Hussman Strategic Advisors's Nutex Health position peaked at $3.46M in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.